Latest Articles

  • Making best use of bone turnover markers to monitor oral bisphosphonate therapy
    Sarah Keller, MD
    Cleveland Clinic Journal of Medicine January 2023, 90 (1) 32-34; DOI: https://doi.org/10.3949/ccjm.90a.22092

    Clinical applications of bone turnover markers can include determining when to start or end a bisphosphonate “holiday” and measuring treatment response.

  • Median rhomboid glossitis caused by tongue-brushing
    Tatsuya Shindo, MD
    Cleveland Clinic Journal of Medicine January 2023, 90 (1) 15-16; DOI: https://doi.org/10.3949/ccjm.90a.21111

    The patient had started vigorous brushing 1 month earlier after being told that she had bad breath.

  • What are my obligations to my incarcerated patient?
    Farah Acher Kaiksow, MD, MPP, Deval Patel, MD and Norman Fost, MD, MPH
    Cleveland Clinic Journal of Medicine January 2023, 90 (1) 18-21; DOI: https://doi.org/10.3949/ccjm.90a.22003

    A court order authorizes a blood transfusion, but the incarcerated patient refuses the transfusion. As the caregiver, am I obligated to follow the court order against the patient’s wishes?

  • Central vision loss in a 44-year-old woman
    Walker M. Schmidt, BS, Nirosha D. Perera, MD, Blake H. Fortes, MD, Benjamin A. Nelson, MD, Wendy M. Smith, MD and Hannah C. Nordhues, MD
    Cleveland Clinic Journal of Medicine January 2023, 90 (1) 35-41; DOI: https://doi.org/10.3949/ccjm.90a.22038

    The patient had a wide range of symptoms and comorbidities, resulting in a complicated differential diagnosis. Careful evaluation eventually led to a focus on sexually transmitted infection.

  • Some complexities of diabetes and the heart
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine January 2023, 90 (1) 13-14; DOI: https://doi.org/10.3949/ccjm.90b.01023

    Patients with diabetes are at greater risk of coronary artery disease than their peers without diabetes. That’s straight and simple. But there the simplicity ends.

  • Bone turnover markers to monitor oral bisphosphonate therapy
    Nikita Ashcherkin, MD, Archna A. Patel, MD, MPH, Alicia Algeciras-Schimnich, PhD and Krupa B. Doshi, MD, FACE
    Cleveland Clinic Journal of Medicine January 2023, 90 (1) 26-31; DOI: https://doi.org/10.3949/ccjm.90a.22002

    Rapid changes in levels of bone turnover markers can be useful in monitoring the effectiveness of therapy and improving adherence to therapy.

  • Evaluation and management of gastroesophageal reflux disease: A brief look at the updated guidelines
    Priya Sasankan, MD and Prashanthi N. Thota, MD, FACG
    Cleveland Clinic Journal of Medicine December 2022, 89 (12) 700-703; DOI: https://doi.org/10.3949/ccjm.89a.22059

    Updated guidelines from the American College of Gastroenterology address the evaluation and management of reflux disease, consequences of long-term PPI therapy, and emerging therapies.

  • A 60-year-old man with prostate cancer and embolic strokes
    Neha K. Reddy, MD, MA, Christian Scherer, DO, Samuel Kessel, MD, MBA and Alejandro Moreno, MBBS, MPH, JD, MACP
    Cleveland Clinic Journal of Medicine December 2022, 89 (12) 705-711; DOI: https://doi.org/10.3949/ccjm.89a.21079

    Step-by-step evaluation of a patient with stage IV prostate cancer and embolic stroke, but no history of heart valve disease, arrhythmia, or coagulopathy.

  • Ignore e-cigarettes at your patient’s peril
    Vania Modesto-Lowe, MD, MPH, Lakshit Jain, MD and Roberto León-Barriera, MD
    Cleveland Clinic Journal of Medicine December 2022, 89 (12) 679-682; DOI: https://doi.org/10.3949/ccjm.89a.22006

    As patients are already using these products, rather than dismiss the use of e-cigarettes, clinicians should provide accurate information to help patients make the best choices for their health.

  • Should ‘daily labs’ be a quality priority in hospital medicine?
    Caleb J. Murphy, MD, MBA and Andrew W. Schram, MD, MBA
    Cleveland Clinic Journal of Medicine December 2022, 89 (12) 685-688; DOI: https://doi.org/10.3949/ccjm.89a.22036

    Evidence shows that unnecessary daily testing is only a minor contributor to anemia and healthcare costs for most inpatients. The effect on patient experience has not been definitively established.

Pages